Valerie Odegard

President, Silverback Therapeutics.

Companies

Odyssey Therapeutics, Inc.Board member May 7, 2026 to now¹
Silverback TherapeuticsPresident Dec 3, 2020 to May 4, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Silverback Therapeutics SPRY61,639 shares³$264.1K at $4.29May 2, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

May 2, 2022Granted 45,233 shares of Silverback Therapeutics³
Feb 1, 2022Granted 16,406 shares of Silverback Therapeutics⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROdyssey Therapeutics, Inc., Board member
2
SEC EDGARSilverback Therapeutics, President
3
SEC EDGARSilverback Therapeutics shares after the filing of May 2, 2022
4
SEC EDGARForm 4 filed Feb 2, 2022